Early PET response to neoadjuvant chemo predicts increased survival in sarcoma patients
An early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
Prior studies by this multidisciplinary team of physician scientists at the Jonsson Cancer Center had shown that use of FDG PET/computed tomography (CT) could determine pathologic response after the first dose of chemotherapy drugs. The researchers then wondered if the patients showing a significant PET response after the first round of chemotherapy also were surviving longer, said Dr. Fritz Eilber, an associate professor of surgical oncology, director of the Sarcoma Program at UCLA's Jonsson Cancer Center and senior author of the study.
"We did find that patients who experienced an early PET response to treatment had significantly increased survival," Eilber said. "This is vital because patients want to know if the drugs are working and what that says about their ultimate outcome."
The study was published April 1, 2012 in Clinical Cancer Research, a peer-reviewed journal of the American Association of Cancer Research.
In this study, 39 patients with soft tissue sarcoma underwent a PET scan to measure their tumor's metabolism, or how much glucose was being taken up by the tumor, prior to getting chemotherapy. The patients were given another PET scan after the first round of chemotherapy. Those whose tumors demonstrated a 25 percent or more decrease in metabolic activity a response considered significant - were determined later to have significant increased survival rates compared to those patients who had less than a 25 percent decrease, Eilber said.
"It's an important finding because we can now identify whether patients are getting the right chemotherapy very quickly," Eilber said. "Patients don't want to have to wait until the cancer recurs or they die to find out whether their chemotherapy worked or not."
Going forward, Eilber and his team are working to design new molecular imaging tools that may tell them even more about a patient's cancer beyond the conventional FDG probe.
"Just looking at the size of the tumor is not good enough anymore," Eilber said. "We want to image what's happening within the tumor in real time."
The study was funded by the In vivo Cellular and Molecular Imaging Center at UCLA's Jonsson Comprehensive Cancer Center and the Department of Energy.
"This study suggests that PET allows survival predictions after the initial cycle of neoadjuvant chemotherapy and might therefore potentially serve as an early endpoint biomarker," the study states. "Such information cannot be derived from CT scanning based on serial tumor size measurements. The ability to assess treatment response early during the course of therapy can potentially guide management decisions. Treatment could be switched from neoadjuvant chemotherapy to immediate surgery in non-responding patients, while it would be continued in responders. Such risk adapted therapy could reduce treatment associated morbidity and costs."
Provided by University of California - Los Angeles
- Using PET/CT imaging, researchers can tell after a single treatment if chemotherapy is working Apr 14, 2009 | not rated yet | 0
- Combining CT, FDG-PET provides more accurate treatments for head and neck cancer patients Apr 29, 2011 | not rated yet | 0
- Scientists develop crystal ball for personalized cancer treatment Feb 02, 2009 | not rated yet | 0
- Quantitative PET imaging finds early determination of effectiveness of cancer treatment Oct 23, 2007 | not rated yet | 0
- PET techniques provide more accurate diagnosis, prognosis in challenging breast cancer cases Feb 06, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer May 24, 2013 | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer May 24, 2013 | 5 / 5 (1) | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer May 24, 2013 | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer May 24, 2013 | 5 / 5 (2) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer May 24, 2013 | 5 / 5 (4) | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
11 hours ago | 5 / 5 (2) | 5
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
3 hours ago | not rated yet | 0
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
11 hours ago | not rated yet | 1
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
11 hours ago | not rated yet | 0
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
11 hours ago | not rated yet | 0